Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Mirum Pharmaceuticals Inc NASDAQ: MIRM-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 12.95
Day High 13.60
Open:13.52
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's product candidate consists of maralixibat, an investigational oral drug in development for progressive familial intrahepatic cholestasis and Alagille syndrome. Mirum Pharmaceuticals Inc. is based in Foster City, United States.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Wire - Mon Nov 22, 7:30AM CST
Business Wire - PRTGAM
Mon Nov 22, 7:30AM CST
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it will participate in the following upcoming virtual investor conferences:
Mirum Pharmaceuticals Sells Rare Pediatric Disease Priority Review Voucher
Business Wire - Wed Nov 17, 7:30AM CST
Business Wire - PRTGAM
Wed Nov 17, 7:30AM CST
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (“PRV”) for $110 million.
Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
Business Wire - Mon Nov 15, 3:01PM CST
Business Wire - PRTGAM
Mon Nov 15, 3:01PM CST
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), today reported financial results for the quarter ended September 30, 2021, and provided a business update.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 12.82 +3.51% increase
on 11/29/21
Period Open:16.54
Price movement based on the high, low and last over the given period.
16.92 -21.60% decrease
on 11/04/21
-3.27 (-19.77%) decrease
since 11/03/21
3-Month 12.82 +3.51% increase
on 11/29/21
Period Open:18.00
Price movement based on the high, low and last over the given period.
21.50 -38.28% decrease
on 09/29/21
-4.73 (-26.28%) decrease
since 09/03/21
52-Week 12.82 +3.51% increase
on 11/29/21
Period Open:24.16
Price movement based on the high, low and last over the given period.
26.31 -49.56% decrease
on 12/10/20
-10.89 (-45.07%) decrease
since 12/03/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies